GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Polaris AI Pharma Corp (XKRX:041910) » Definitions » Cyclically Adjusted PS Ratio

Polaris AI Pharma (XKRX:041910) Cyclically Adjusted PS Ratio : 1.74 (As of Jun. 05, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Polaris AI Pharma Cyclically Adjusted PS Ratio?

As of today (2025-06-05), Polaris AI Pharma's current share price is ₩8730.00. Polaris AI Pharma's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₩5,003.11. Polaris AI Pharma's Cyclically Adjusted PS Ratio for today is 1.74.

The historical rank and industry rank for Polaris AI Pharma's Cyclically Adjusted PS Ratio or its related term are showing as below:

XKRX:041910' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.04   Med: 2.01   Max: 3.97
Current: 1.62

During the past years, Polaris AI Pharma's highest Cyclically Adjusted PS Ratio was 3.97. The lowest was 1.04. And the median was 2.01.

XKRX:041910's Cyclically Adjusted PS Ratio is ranked better than
61.65% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.155 vs XKRX:041910: 1.62

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Polaris AI Pharma's adjusted revenue per share data for the three months ended in Mar. 2025 was ₩959.149. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₩5,003.11 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Polaris AI Pharma Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Polaris AI Pharma's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polaris AI Pharma Cyclically Adjusted PS Ratio Chart

Polaris AI Pharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.79 2.11 1.52 1.42 1.08

Polaris AI Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.15 1.57 1.40 1.08 1.09

Competitive Comparison of Polaris AI Pharma's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Polaris AI Pharma's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polaris AI Pharma's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Polaris AI Pharma's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Polaris AI Pharma's Cyclically Adjusted PS Ratio falls into.


;
;

Polaris AI Pharma Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Polaris AI Pharma's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=8730.00/5003.11
=1.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polaris AI Pharma's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Polaris AI Pharma's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=959.149/122.5900*122.5900
=959.149

Current CPI (Mar. 2025) = 122.5900.

Polaris AI Pharma Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 964.538 100.051 1,181.828
201509 271.249 100.111 332.156
201512 1,193.326 100.220 1,459.681
201603 885.266 100.561 1,079.194
201606 1,092.176 100.791 1,328.395
201609 790.131 101.461 954.672
201612 978.360 101.561 1,180.934
201703 893.931 102.851 1,065.497
201706 716.764 102.611 856.320
201709 732.123 103.491 867.239
201712 899.379 102.991 1,070.531
201803 726.009 104.101 854.954
201806 815.724 104.130 960.331
201809 1,418.943 105.651 1,646.450
201812 1,221.835 104.351 1,435.398
201903 725.221 104.491 850.838
201906 860.389 104.881 1,005.665
201909 1,127.428 105.200 1,313.793
201912 1,278.762 105.121 1,491.262
202003 1,072.829 105.354 1,248.342
202006 1,301.950 105.112 1,518.441
202009 1,449.836 106.198 1,673.629
202012 1,294.482 105.765 1,500.401
202103 1,191.915 107.357 1,361.035
202106 1,340.586 107.579 1,527.650
202109 1,210.731 108.759 1,364.698
202112 1,428.261 109.676 1,596.428
202203 1,631.900 111.848 1,788.629
202206 1,201.789 114.072 1,291.526
202209 1,210.249 114.715 1,293.327
202212 1,267.718 115.179 1,349.285
202303 1,472.465 116.507 1,549.339
202306 1,369.149 117.182 1,432.335
202309 1,256.418 118.964 1,294.718
202312 1,391.668 118.837 1,435.617
202403 1,221.048 120.123 1,246.123
202406 1,258.883 120.007 1,285.976
202409 1,127.583 120.861 1,143.712
202412 1,220.964 121.135 1,235.627
202503 959.149 122.590 959.149

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Polaris AI Pharma  (XKRX:041910) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Polaris AI Pharma Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Polaris AI Pharma's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Polaris AI Pharma Business Description

Traded in Other Exchanges
N/A
Address
25 Balangongdan-ro, Hyangnam-eup, Gyeonggi-do, Hwaseong-si, KOR
Polaris AI Pharma Corp is engaged in the production of raw pharmaceutical ingredients. It focuses on generic drugs and produces about 40 types of raw medicines, including asthma treatments, gastric ulcer treatments, and alcohol dependence treatments, and supplies them domestically and internationally.

Polaris AI Pharma Headlines

No Headlines